文献速递介入腹部MR

兔VX2肝肿瘤模型中使用不同化疗栓塞方案行经导管动脉化疗栓塞后代谢与免疫反应的比较

Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model.
PubMed 文献 · Eur Radiol · 2021-10-31

在兔VX2肝肿瘤模型中,比较传统TACE、Oncozene™药物洗脱微球TACE及LUMI™药物洗脱微球TACE单独或联合碳酸氢钠对肿瘤微环境pH及免疫细胞浸润的影响;结果显示化疗栓塞方案的选择强烈影响治疗后肿瘤细胞外pH及免疫细胞聚集和浸润能力。

要点

  • 传统TACE联合预先输注碳酸氢钠可显著提高肿瘤细胞外pH(p=0.0025)。
  • 抗原提呈细胞和T淋巴细胞的瘤周浸润与瘤内积聚模式取决于化疗栓塞方案的选择。
  • 多柔比星洗脱LUMI™微球联合碳酸氢钠输注时瘤内免疫细胞存在最强(HLA-DR+细胞阳性指数0.47,CD3+细胞阳性指数0.62)。

核心结论

  • 化疗栓塞方案的选择强烈影响TACE治疗后肿瘤微环境的细胞外pH及免疫细胞在肿瘤组织中聚集和浸润的能力。

研究设计与样本

  • 兔VX2肝肿瘤模型研究,将荷瘤兔分为五组,在动脉内治疗前后行MRI及基于BIRDS的细胞外pH成像,并以免疫组化(PCNA、TUNEL、HLA-DR、CD3)验证影像结果,统计分析采用Mann-Whitney U检验。

关键影像表现/征象

  • 传统TACE联合预先输注碳酸氢钠较对照组显著提高肿瘤细胞外pH(p=0.0175)。
  • 传统TACE联合预先输注碳酸氢钠较单用传统TACE显著提高肿瘤细胞外pH(p=0.0025)。
  • 对照组可见瘤周HLA-DR+抗原提呈细胞和CD3+ T淋巴细胞积聚。
  • 传统TACE治疗组免疫浸润减少,联合碳酸氢钠后恢复。
  • Oncozene™药物洗脱微球TACE诱导中度瘤内和显著瘤周浸润,联合碳酸氢钠后略有减少。

诊断标准与关键数值

  • 细胞外pH采用基于BIRDS的MRI成像测定。
  • 免疫细胞浸润以HLA-DR+细胞和CD3+细胞阳性指数评估,多柔比星洗脱LUMI™微球联合碳酸氢钠组HLA-DR+细胞阳性指数为0.47,CD3+细胞阳性指数为0.62。

临床应用与阅片要点

  • 传统TACE联合预先碳酸氢钠输注可使肿瘤细胞外pH趋向更接近生理值(p=0.0025)。
  • 多柔比星洗脱LUMI™微球联合碳酸氢钠输注在所有治疗组中产生最强的瘤内免疫细胞存在。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The goal of this study was to investigate the effects of TACE using Lipiodol, Oncozene™ drug-eluting embolics (DEEs), or LUMI™-DEEs alone, or combined with bicarbonate on the metabolic and immunological tumor microenvironment in a rabbit VX2 tumor model.

METHODS: VX2 liver tumor-bearing rabbits were assigned to five groups. MRI and extracellular pH (pHe) mapping using Biosensor Imaging of Redundant Deviation in Shifts (BIRDS) were performed before and after intra-arterial therapy with conventional TACE (cTACE), DEE-TACE with Idarubicin-eluting Oncozene™-DEEs, or Doxorubicin-eluting LUMI™-DEEs, each with or without prior bicarbonate infusion, and in untreated rabbits or treated with intra-arterial bicarbonate only. Imaging results were validated with immunohistochemistry (IHC) staining of cell viability (PCNA, TUNEL) and immune response (HLA-DR, CD3). Statistical analysis was performed using Mann-Whitney U test.

RESULTS: pHe mapping revealed that combining cTACE with prior bicarbonate infusion significantly increased tumor pHe compared to control (p = 0.0175) and cTACE alone (p = 0.0025). IHC staining revealed peritumoral accumulation of HLA-DR+ antigen-presenting cells and CD3 + T-lymphocytes in controls. cTACE-treated tumors showed reduced immune infiltration, which was restored through combination with bicarbonate. DEE-TACE with Oncozene™-DEEs induced moderate intratumoral and marked peritumoral infiltration, which was slightly reduced with bicarbonate. Addition of bicarbonate prior to LUMI™-beads enhanced peritumoral immune cell infiltration compared to LUMI™-beads alone and resulted in the strongest intratumoral immune cell infiltration across all treated groups.

CONCLUSIONS: The choice of chemoembolic regimen for TACE strongly affects post-treatment TME pHe and the ability of immune cells to accumulate and infiltrate the tumor tissue.

KEY POINTS: • Combining conventional transarterial chemotherapy with prior bicarbonate infusion increases the pHe towards a more physiological value (p = 0.0025). • Peritumoral infiltration and intratumoral accumulation patterns of antigen-presenting cells and T-lymphocytes after transarterial chemotherapy were dependent on the choice of the chemoembolic regimen. • Combination of intra-arterial treatment with Doxorubicin-eluting LUMI™-beads and bicarbonate infusion resulted in the strongest intratumoral presence of immune cells (positivity index of 0.47 for HLADR+-cells and 0.62 for CD3+-cells).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Doemel, Santana, Savic, et al. Comparison of metabolic and immunologic responses to transarterial chemoembolization with different chemoembolic regimens in a rabbit VX2 liver tumor model. Eur Radiol. 2021. PMID: 34718844. doi:10.1007/s00330-021-08337-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。